<DOC>
	<DOCNO>NCT00320203</DOCNO>
	<brief_summary>The purpose study evaluate safety , efficacy , duration effect single administration Anecortave Acetate Depot treatment elevate intraocular pressure ( IOP ) patient open-angle glaucoma .</brief_summary>
	<brief_title>Anecortave Acetate Patients With Open-angle Glaucoma</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Anecortave</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<criteria>Patients 18 year age old openangle glaucoma . Other protocoldefined inclusion criterion may apply . Patients openangle glaucoma pseudoexfoliation pigment dispersion component . Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>open-angle</keyword>
	<keyword>glaucoma</keyword>
</DOC>